No Data
No Data
Heron Therapeutics Reaffirms Treatment Supply After Hurricane Helene
Heron Therapeutics: CINVANTI, in Combination With Other Antiemetic Agents, Is Indicated in Adults for Prevention of Nausea and Vomiting Associated With Cancer Chemotherapy >HRTX
Heron Therapeutics: Marion Facility Is Believed to Supply Up to 60% of the IV Fluid Market in U.S. >HRTX
Heron Therapeutics: Potential Disruption in Supply of Intravenously Administered Fluids Is Result of Temporary Closure of Suppliers' Manufacturing Site in Marion, N.C., Impacted by Hurricane Helene >HRTX
Express News | Heron Therapeutics Reaffirms Availability and Ample Supply of Cinvanti®, Sustol®, and Aponvie® as Alternatives During the Potential Shortage of Intravenous Fluids
Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI, SUSTOL, and APONVIE as Alternatives During the Potential Shortage of Intravenous Fluids
No Data
No Data